NAIAD is a drug discovery startup creating novel bioactive small molecules targeting G-protein coupled receptors (GPCRs).
NAIAD’s computational simulation and deep learning based platform leverages structural biological information to virtually screen billions of molecules against specific GPCRs, looking for the ones that present the desired biological profile.
The team of the company is composed of senior industry and academic researchers, biotech entrepreneurs and bioinformatics/chemoinformatics data scientists..
Our unique capabilities of protein motion sampling and ultra-high throughput virtual screening enable NAIAD to effectively search and screen a chemical space containing billions of molecules, hunting the ones with the highest potential of biological activity against the desired GPCRs, selecting the ones with the best pharmacodynamics and pharmacokinetics potential for further wet tests.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Alameda Caulim, 115, Sala 205,brazil
- Industry
- Biotechnology
- Website
- http://www.naiadd.com
- Keywords
- Drug Design, Bioinformatics, Pharma.
- HQ
- São Caetano do Sul, São Paulo
Naiad Drug Design Questions
Naiad Drug Design's website is http://www.naiadd.com
Naiad Drug Design's LinkedIn profile is https://br.linkedin.com/company/naiadd
Naiad Drug Design has
9 employees.
View email and phone details for 9
employees at Naiad Drug Design.
Naiad Drug Design's industry is
Biotechnology
Naiad Drug Design's top competitors are
Eva Scientific,
Arborea Biotech,
Mirscience Therapeutics,
Celluris,
Bioptamers,
Bioinfood,
Xenobr,
Bcgene,
Vyro Bio,
Abiquifi.
Naiad Drug Design's categories are Biotechnology
Naiad Drug Design's founding year is 2018
